THE EUROPEAN LEAD FACTORY OF SHELVED DRUG CANDIDATES is an historic initiative. Previously bunkered, many of these molecules have been tested for safety in man. They were developed because they were potent biological modifiers. Opening the repurposing door to academia and industry is valuable. This is one of a number of initiatives that Big Pharma is taking to remedy a broken discovery model. Everyone wins.
http://pipeline.corante.com/archives/2013/02/12/the_european_lead_factory.php
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022